Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Promotion of good mental health, prevention, and early intervention before/at the onset of mental disorders improve outcomes. However, the range and peak ages at onset for mental disorders are not fully established. To provide robust, global epidemiological estimates of age at onset for mental disorders, we conducted a PRISMA/MOOSE-compliant systematic review with meta-analysis of birth cohort/cross-sectional/cohort studies, representative of the general population, reporting age at onset for any ICD/DSM-mental disorders, identified in PubMed/Web of Science (up to 16/05/2020) (PROSPERO:CRD42019143015). Co-primary outcomes were the proportion of individuals with onset of mental disorders before age 14, 18, 25, and peak age at onset, for any mental disorder and across International Classification of Diseases 11 diagnostic blocks. Median age at onset of specific disorders was additionally investigated. Across 192 studies ( n = 708,561) included, the proportion of individuals with onset of any mental disorders before the ages of 14, 18, 25 were 34.6%, 48.4%, 62.5%, and peak age was 14.5 years ( k = 14, median = 18, interquartile range (IQR) = 11–34). For diagnostic blocks, the proportion of individuals with onset of disorder before the age of 14, 18, 25 and peak age were as follows: neurodevelopmental disorders: 61.5%, 83.2%, 95.8%, 5.5 years ( k = 21, median=12, IQR = 7–16), anxiety/fear-related disorders: 38.1%, 51.8%, 73.3%, 5.5 years ( k = 73, median = 17, IQR = 9–25), obsessive-compulsive/related disorders: 24.6%, 45.1%, 64.0%, 14.5 years ( k = 20, median = 19, IQR = 14–29), feeding/eating disorders/problems: 15.8%, 48.1%, 82.4%, 15.5 years ( k = 11, median = 18, IQR = 15–23), conditions specifically associated with stress disorders: 16.9%, 27.6%, 43.1%, 15.5 years ( k = 16, median = 30, IQR = 17–48), substance use disorders/addictive behaviours: 2.9%, 15.2%, 48.8%, 19.5 years ( k = 58, median = 25, IQR = 20–41), schizophrenia-spectrum disorders/primary psychotic states: 3%, 12.3%, 47.8%, 20.5 years ( k = 36, median = 25, IQR = 20–34), personality disorders/related traits: 1.9%, 9.6%, 47.7%, 20.5 years ( k = 6, median = 25, IQR = 20–33), and mood disorders: 2.5%, 11.5%, 34.5%, 20.5 years ( k = 79, median = 31, IQR = 21–46). No significant difference emerged by sex, or definition of age of onset. Median age at onset for specific mental disorders mapped on a time continuum, from phobias/separation anxiety/autism spectrum disorder/attention deficit hyperactivity disorder/social anxiety (8-13 years) to anorexia nervosa/bulimia nervosa/obsessive-compulsive/binge eating/cannabis use disorders (17-22 years), followed by schizophrenia, personality, panic and alcohol use disorders (25-27 years), and finally post-traumatic/depressive/generalized anxiety/bipolar/acute and transient psychotic disorders (30-35 years), with overlap among groups and no significant clustering. These results inform the timing of good mental health promotion/preventive/early intervention, updating the current mental health system structured around a child/adult service schism at age 18.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“all major syndromes constituting approximately 75% of mental disorders begin before the age of 25 years [9, 10]”
From Towards a youth mental health paradigm: a perspective and roadmap (2023) · cites this paper as [9]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most mental disorders have a typical onset between 12 and 25 years of age, highlighting the importance of this period for the pathogenesis, diagnosis, and treatment of mental ill-health.”
From Towards a youth mental health paradigm: a perspective and roadmap (2023) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the peak incidence of mental disorders during youth [9, 10]”
From Towards a youth mental health paradigm: a perspective and roadmap (2023) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the large unmet need in young people that has recently dramatically accelerated [9]”
From Towards a youth mental health paradigm: a perspective and roadmap (2023) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Relative to adolescents and adults, emerging adults experience the highest incidence and prevalence of substance use disorders (SUDs) and comorbid mental health disorders (2-4).”
From Initial insights from a quality improvement initiative to develop an evidence-informed young adult substance use program (2022) · cites this paper as [4]
Experimental — accuracy not yet measured
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“We performed a systematic review adhering to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) recommendations [31] (e-Table 1) and the meta-analysis of observational studies in epidemiology (MOOSE) guidelines (e-Table 2) [32].”
MethodPreferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Bootstrap Methods and their Application
Davison, A. C., & Hinkley, D. V. (1997) · doi:10.1017/cbo9780511802843 · Cited by 7,350
Bootstrap Methods and Their Application
Loughin, T. M., Davison, A. C., & Hinkley, D. V. (1999) · Journal of the American Statistical Association · doi:10.2307/2669707 · Cited by 5,418
Why do many psychiatric disorders emerge during adolescence?
Paus, T., Keshavan, M., & Giedd, J. N. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2513 · Cited by 3,123 · cited 2×
“The meta-epidemiologic results of this work show that mental disorders have onset when dramatic biological changes in the brain occur, from childhood, through adolescence, to adulthood, that involves grey-matter density, cerebral metabolic rate, synaptic density, white matter growth and myelination [41].”
BackgroundWalker, E. R., McGee, R. E., & Druss, B. G. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2502 · Cited by 2,976
Global burden of disease in young people aged 10–24 years: a systematic analysis
Gore, F. M., Bloem, P. J., Patton, G. C., Ferguson, J., Joseph, V., Coffey, C., Sawyer, S. M., & Mathers, C. D. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60512-6 · Cited by 2,301 · cited 1×
“Given that mental disorders are one of the five most common ailments leading to morbidity, mortality and dysfunction among young people worldwide [45], the current findings are relevant to policymakers and healthcare providers.”
BackgroundSaha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Hjorthøj, C., Stürup, A. E., McGrath, J. J., & Nordentoft, M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30078-0 · Cited by 1,304
Schizophrenia: an integrated sociodevelopmental-cognitive model
Howes, O. D., & Murray, R. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62036-x · Cited by 864
Correll, C. U., Galling, B., Pawar, A., Krivko, A., Bonetto, C., Ruggeri, M., Craig, T. J., Nordentoft, M., Srihari, V. H., Guloksuz, S., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0623 · Cited by 826 · cited 1×
“Early interventions at the first onset of mental disorders can improve several outcomes [5, 6].”
BackgroundSelf-citationNordentoft, M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Laursen, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055176 · Cited by 778
Werner-Seidler, A., Perry, Y., Calear, A. L., Newby, J. M., & Christensen, H. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.10.005 · Cited by 773
Adult mental health disorders and their age at onset
Jones, P. B. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.119164 · Cited by 701 · cited 5×
“However, we perprotocol included the highest-quality studies to study age at onset according to previous recommendations [30].”
BackgroundMethodInfluentialSelf-citationImproving outcomes of first‐episode psychosis: an overview
Fusar‐Poli, P., McGorry, P. D., & Kane, J. M. (2017) · World Psychiatry · doi:10.1002/wps.20446 · Cited by 575 · cited 2×
“Early interventions at the first onset of mental disorders can improve several outcomes [5, 6].”
BackgroundSelf-citationWhat causes psychosis? An umbrella review of risk and protective factors
Radua, J., Ramella‐Cravaro, V., Ioannidis, J. P. A., Reichenberg, A., Phiphopthatsanee, N., Amir, T., Yenn Thoo, H., Oliver, D., Davies, C., Morgan, C., et al. (2018) · World Psychiatry · doi:10.1002/wps.20490 · Cited by 553 · cited 1×
“Targeted preventive approaches involve screening programmes in asymptomatic individuals who have significant risk factors for certain psychiatric disorders [7, 22, 23] (primary selective prevention [7, 8]) or public health campaigns in the general population (primary universal prevention) [7, 8, 24].”
BackgroundSelf-citationAltering the course of schizophrenia: progress and perspectives
Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516
Self-citationPreventive psychiatry: a blueprint for improving the mental health of young people
Fusar‐Poli, P., Correll, C. U., Arango, C., Berk, M., Patel, V., & Ioannidis, J. P. A. (2021) · World Psychiatry · doi:10.1002/wps.20869 · Cited by 497 · cited 5×
“These results suggest that the next generation of mental health research should prioritise designing and funding global early interventions [5, 46] and indicated, selective and/or universal preventive interventions for mental disorders during mid/ late adolescence and young adulthood that are currently lacking [8].”
BackgroundInfluentialSelf-citationBeyond the “at risk mental state” concept: transitioning to transdiagnostic psychiatry
McGorry, P. D., Hartmann, J. A., Spooner, R., & Nelson, B. (2018) · World Psychiatry · doi:10.1002/wps.20514 · Cited by 488 · cited 1×
“For example, an indicated prevention and early intervention model of care for mood disorders, and schizophrenia-spectrum/primary psychotic disorders should ideally integrate low-threshold entry points for individuals of age younger than 18, supplemented by systematic promotion of good mental health, proactive screenin…”
BackgroundPrevention of Psychosis: Advances in Detection, Prognosis, and Intervention
Fusar-Poli, P., Salazar de Pablo, G., Correll, C. U., Meyer-Lindenberg, A., Millan, M. J., Borgwardt, S., Galderisi, S., Bechdolf, A., Pfennig, A., Kessing, L. V., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.4779 · Cited by 476
Self-citationTransdiagnostic psychiatry: a systematic review
Fusar‐Poli, P., Solmi, M., Brondino, N., Davies, C., Chae, C., Politi, P., Borgwardt, S., Lawrie, S. M., Parnas, J., & McGuire, P. (2019) · World Psychiatry · doi:10.1002/wps.20631 · Cited by 409 · cited 1×
“It also represents the most comprehensive approach, encompassing all ICD-11 diagnostic spectra for which we found eligible studies, allowing comparative transdiagnostic analyses across different categories of mental disorders [39, 40].”
BackgroundSelf-citationSalazar de Pablo, G., Radua, J., Pereira, J., Bonoldi, I., Arienti, V., Besana, F., Soardo, L., Cabras, A., Fortea, L., Catalan, A., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0830 · Cited by 375 · cited 1×
“For example, young people with attenuated symptoms for psychosis [10–13] and functional impairments accumulate several risk factors and have a 25% probability of developing the disorder over 3 years [14].”
BackgroundSelf-citationWhat is good mental health? A scoping review
Fusar-Poli, P., Salazar de Pablo, G., De Micheli, A., Nieman, D. H., Correll, C. U., Kessing, L. V., Pfennig, A., Bechdolf, A., Borgwardt, S., Arango, C., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.12.105 · Cited by 356 · cited 1×
“A further complementary approach is to promote good mental health, as opposed to preventing mental disorders [7, 25, 26].”
BackgroundSelf-citationRisk and protective factors for mental disorders beyond genetics: an evidence‐based atlas
Arango, C., Dragioti, E., Solmi, M., Cortese, S., Domschke, K., Murray, R. M., Jones, P. B., Uher, R., Carvalho, A. F., Reichenberg, A., et al. (2021) · World Psychiatry · doi:10.1002/wps.20894 · Cited by 319
Self-citationKöhler, C. A., Evangelou, E., Stubbs, B., Solmi, M., Veronese, N., Belbasis, L., Bortolato, B., Melo, M. C. A., Coelho, C. A., Fernandes, B. S., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.05.020 · Cited by 302
Self-citationDavies, C., Segre, G., Estradé, A., Radua, J., De Micheli, A., Provenzani, U., Oliver, D., Salazar de Pablo, G., Ramella-Cravaro, V., Besozzi, M., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30057-2 · Cited by 301 · cited 1×
“Many of the risk and protective factors that impact the neurodevelopment of individuals with these disorders are known [23, 47–52], and some of them may even impact the pre or perinatal phases [53].”
BackgroundSelf-citationEarly Intervention in Psychosis: Obvious, Effective, Overdue
McGorry, P. D. (2015) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000284 · Cited by 289
Age at onset and the outcomes of schizophrenia: A systematic review and meta‐analysis
Immonen, J., Jääskeläinen, E., Korpela, H., & Miettunen, J. (2017) · Early Intervention in Psychiatry · doi:10.1111/eip.12412 · Cited by 280
Kim, J. Y., Son, M. J., Son, C. Y., Radua, J., Eisenhut, M., Gressier, F., Koyanagi, A., Carvalho, A. F., Stubbs, B., Solmi, M., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30181-6 · Cited by 271
Self-citationTortella-Feliu, M., Fullana, M. A., Pérez-Vigil, A., Torres, X., Chamorro, J., Littarelli, S. A., Solanes, A., Ramella-Cravaro, V., Vilar, A., González-Parra, J. A., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.013 · Cited by 253
Self-citationLack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis
Davies, C., Cipriani, A., Ioannidis, J. P. A., Radua, J., Stahl, D., Provenzani, U., McGuire, P., & Fusar‐Poli, P. (2018) · World Psychiatry · doi:10.1002/wps.20526 · Cited by 229
Self-citationFusar-Poli, P. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00355 · Cited by 218 · cited 2×
“Future mental health reforms could leverage and refine clinical high-risk services for young people at risk of psychosis, which typically accepts referrals aged 14–35 years and therefore provide essential transitional care to this vulnerable young population [15, 17, 58].”
BackgroundSelf-citationThe Clinical High-Risk State for Psychosis (CHR-P), Version II
Fusar-Poli, P. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw158 · Cited by 217
Self-citationFusar-Poli, P., Byrne, M., Badger, S., Valmaggia, L. R., & McGuire, P. K. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2012.08.002 · Cited by 197
Self-citationBortolato, B., Köhler, C. A., Evangelou, E., León‐Caballero, J., Solmi, M., Stubbs, B., Belbasis, L., Pacchiarotti, I., Kessing, L. V., Berk, M., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12490 · Cited by 195
Self-citationDemjaha, A., MacCabe, J. H., & Murray, R. M. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr100 · Cited by 173
Catalan, A., Salazar de Pablo, G., Vaquerizo Serrano, J., Mosillo, P., Baldwin, H., Fernández‐Rivas, A., Moreno, C., Arango, C., Correll, C. U., Bonoldi, I., et al. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13322 · Cited by 171
Self-citationGender difference in age at onset of schizophrenia: a meta-analysis
Eranti, S. V., MacCabe, J. H., Bundy, H., & Murray, R. M. (2013) · Psychological Medicine · doi:10.1017/s003329171200089x · Cited by 168
Belbasis, L., Köhler, C. A., Stefanis, N., Stubbs, B., van Os, J., Vieta, E., Seeman, M. V., Arango, C., Carvalho, A. F., & Evangelou, E. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12847 · Cited by 148
Self-citationLindow, J. C., Hughes, J. L., South, C., Minhajuddin, A., Gutierrez, L., Bannister, E., Trivedi, M. H., & Byerly, M. J. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.01.006 · Cited by 138 · cited 1×
“Targeted preventive approaches involve screening programmes in asymptomatic individuals who have significant risk factors for certain psychiatric disorders [7, 22, 23] (primary selective prevention [7, 8]) or public health campaigns in the general population (primary universal prevention) [7, 8, 24].”
BackgroundRisk factors in early and late onset schizophrenia
Chen, L., Selvendra, A., Stewart, A., & Castle, D. J. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.09.009 · Cited by 117 · cited 1×
“Unfortunately, the peak ages and ranges at onset for mental disorders are not fully established, with conflicting findings across [27, 28] and within studies [29], partly due to methodological limitations, including selection biases in recruitment for clinical studies [30].”
BackgroundPreventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
Fusar-Poli, P., Davies, C., Solmi, M., Brondino, N., De Micheli, A., Kotlicka-Antczak, M., Shin, J. I., & Radua, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00764 · Cited by 108
Self-citationSalazar de Pablo, G., De Micheli, A., Nieman, D. H., Correll, C. U., Kessing, L. V., Pfennig, A., Bechdolf, A., Borgwardt, S., Arango, C., van Amelsvoort, T., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.10.007 · Cited by 104 · cited 1×
“A further complementary approach is to promote good mental health, as opposed to preventing mental disorders [7, 25, 26].”
BackgroundSelf-citationInterventions for prodromal stage of psychosis
Bosnjak Kuharic, D., Kekin, I., Hew, J., Rojnic Kuzman, M., & Puljak, L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012236.pub2 · Cited by 103
Salazar de Pablo, G., Catalan, A., & Fusar-Poli, P. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3561 · Cited by 103
Self-citationKotlicka‐Antczak, M., Podgórski, M., Oliver, D., Maric, N. P., Valmaggia, L., & Fusar‐Poli, P. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.12950 · Cited by 92 · cited 1×
“Future mental health reforms could leverage and refine clinical high-risk services for young people at risk of psychosis, which typically accepts referrals aged 14–35 years and therefore provide essential transitional care to this vulnerable young population [15, 17, 58].”
BackgroundSelf-citationEstablishing a clinical service to prevent psychosis: What, how and when? Systematic review
Salazar de Pablo, G., Estradé, A., Cutroni, M., Andlauer, O., & Fusar-Poli, P. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01165-x · Cited by 83 · cited 1×
“Future mental health reforms could leverage and refine clinical high-risk services for young people at risk of psychosis, which typically accepts referrals aged 14–35 years and therefore provide essential transitional care to this vulnerable young population [15, 17, 58].”
BackgroundSelf-citationTuomainen, H., Schulze, U., Warwick, J., Paul, M., Dieleman, G. C., Franić, T., Madan, J. J., Maras, A., McNicholas, F., Purper‐Ouakil, D., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1758-z · Cited by 79 · cited 1×
“seen in adulthood show a peak of onset before age 18, such a bifurcated mental health system is not evidence-based and may disadvantage individuals with developmental disorders from accessing and receiving adequate and continuous care [62].”
BackgroundNeurodevelopmental theory of depression
Gałecki, P., & Talarowska, M. E. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.023 · Cited by 71
Fullana, M. A., Tortella-Feliu, M., Fernández de la Cruz, L., Chamorro, J., Pérez-Vigil, A., Ioannidis, J. P. A., Solanes, A., Guardiola, M., Almodóvar, C., Miranda-Olivos, R., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291719001247 · Cited by 71
Self-citationHoarding: A meta‐analysis of age of onset
Zaboski, B. A., Merritt, O. A., Schrack, A. P., Gayle, C., Gonzalez, M., Guerrero, L. A., Dueñas, J. A., Soreni, N., & Mathews, C. A. (2019) · Depression and Anxiety · doi:10.1002/da.22896 · Cited by 69
Fusar-Poli, P., Spencer, T., De Micheli, A., Curzi, V., Nandha, S., & McGuire, P. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.08.002 · Cited by 57
Self-citationLai, E. S. Y., Kwok, C.-L., Wong, P. W. C., Fu, K.-W., Law, Y.-W., & Yip, P. S. F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149854 · Cited by 50
Fusar-Poli, P., Bauer, M., Borgwardt, S., Bechdolf, A., Correll, C. U., Do, K. Q., Domschke, K., Galderisi, S., Kessing, L. V., Koutsouleris, N., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.006 · Cited by 48 · cited 2×
“Targeted preventive approaches involve screening programmes in asymptomatic individuals who have significant risk factors for certain psychiatric disorders [7, 22, 23] (primary selective prevention [7, 8]) or public health campaigns in the general population (primary universal prevention) [7, 8, 24].”
BackgroundSelf-citationTRANSD recommendations: improving transdiagnostic research in psychiatry
Fusar‐Poli, P. (2019) · World Psychiatry · doi:10.1002/wps.20681 · Cited by 43 · cited 1×
“It also represents the most comprehensive approach, encompassing all ICD-11 diagnostic spectra for which we found eligible studies, allowing comparative transdiagnostic analyses across different categories of mental disorders [39, 40].”
BackgroundSelf-citationBurke, A. S., Shapero, B. G., Pelletier-Baldelli, A., Deng, W. Y., Nyer, M. B., Leathem, L., Namey, L., Landa, C., Cather, C., & Holt, D. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.01030 · Cited by 42 · cited 1×
“Targeted preventive approaches involve screening programmes in asymptomatic individuals who have significant risk factors for certain psychiatric disorders [7, 22, 23] (primary selective prevention [7, 8]) or public health campaigns in the general population (primary universal prevention) [7, 8, 24].”
BackgroundLeavey, G., McGrellis, S., Forbes, T., Thampi, A., Davidson, G., Rosato, M., Bunting, B., Divin, N., Hughes, L., Toal, A., et al. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01684-z · Cited by 41
Kyrrestad, H., Adolfsen, F., Handegård, B. H., Natvig, H., Eisemann, M. R., Martinussen, M., & Koposov, R. A. (2015) · BMC Public Health · doi:10.1186/s12889-015-1704-7 · Cited by 40
Russet, F., Humbertclaude, V. T., Dieleman, G. C., Dodig‐Ćurković, K., Hendrickx, G., Kovač, V., McNicholas, F., Maras, A., Santosh, P., Paul, M., et al. (2019) · BMC Medical Education · doi:10.1186/s12909-019-1576-0 · Cited by 39
The age at onset of psychosis and tobacco use: a systematic meta-analysis
Myles, N., Newall, H. D., Compton, M. T., Curtis, J., Nielssen, O. B., & Large, M. M. B. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-011-0431-3 · Cited by 33
Fagerlund, B., Pantelis, C., Jepsen, J. R. M., Raghava, J. M., Rostrup, E., Thomas, M. B., Nielsen, M. Ø., Bojesen, K. B., Jensen, K. G., Decara, M. S., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720000409 · Cited by 29 · cited 1×
“Unfortunately, the peak ages and ranges at onset for mental disorders are not fully established, with conflicting findings across [27, 28] and within studies [29], partly due to methodological limitations, including selection biases in recruitment for clinical studies [30].”
BackgroundSelf-citationPredictors of outcome in early onset schizophrenia: a 10-year follow-up study
Xu, L., Guo, Y., Cao, Q., Li, X., Mei, T., Ma, Z., Tang, X., Ji, Z.-Z., Yang, L., & Liu, J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-2484-x · Cited by 25 · cited 1×
“Unfortunately, the peak ages and ranges at onset for mental disorders are not fully established, with conflicting findings across [27, 28] and within studies [29], partly due to methodological limitations, including selection biases in recruitment for clinical studies [30].”
BackgroundSolmi, M., Durbaba, S., Ashworth, M. J., & Fusar‐Poli, P. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12908 · Cited by 14
Self-citation
Research works printed but not linked: 1
- McGorry PD Hartmann JA Spooner R Nelson B Beyond the "at risk mental state" concept: transitioning to transdiagnostic psychiatry World Psychiatry 2018 17 133 42 29856558 PMC5980504 · DOI · Paper page
Cited by
Brain charts for the human lifespan
Bethlehem, R. A. I., Seidlitz, J., White, S. R., Vogel, J. W., Anderson, K. M., Adamson, C., Adler, S., Alexopoulos, G. S., Anagnostou, E., Areces-Gonzalez, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04554-y · Cited by 1,794
Self-citationThe social determinants of mental health and disorder: evidence, prevention and recommendations
Kirkbride, J. B., Anglin, D. M., Colman, I., Dykxhoorn, J., Jones, P. B., Patalay, P., Pitman, A., Soneson, E., Steare, T., Wright, T., et al. (2024) · World Psychiatry · doi:10.1002/wps.21160 · Cited by 1,253
“Although the majority of mental disorders manifest during ad olescence 19 , they are often rooted much earlier in development.”
BackgroundSelf-citationMarx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 768
Self-citationKieling, C., Buchweitz, C., Caye, A., Silvani, J., Ameis, S. H., Brunoni, A. R., Cost, K. T., Courtney, D. B., Georgiades, K., Merikangas, K. R., et al. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.5051 · Cited by 687
The Lancet Psychiatry Commission on youth mental health
McGorry, P. D., Mei, C., Dalal, N., Alvarez-Jimenez, M., Blakemore, S.-J., Browne, V., Dooley, B., Hickie, I. B., Jones, P. B., McDaid, D., et al. (2024) · The Lancet Psychiatry · doi:10.1016/s2215-0366(24)00163-9 · Cited by 663
Self-citation
Metadata
- Authors
- Solmi, M., Radua, J., Olivola, M., Croce, E., Soardo, L., Salazar de Pablo, G., Il Shin, J., Kirkbride, J. B., Jones, P., Kim, J. H., Kim, J. Y., Carvalho, A. F., Seeman, M. V., Correll, C. U., & Fusar-Poli, P.
- Affiliations
- University of Padua (IT)
- King's College London (GB)
- University of Ferrara (IT)
- University of Pavia (IT)
- University College London (GB)
- National Health Service (GB)
- Yonsei University (KR)
- University of Toronto (CA)
- Feinstein Institute for Medical Research (US)
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 2021-06-02
- Volume
- 27
- Issue
- 1
- Pages
- 281-295
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC8960395
- OpenAlex
- W3164324796
- Cited by
- 3,835
- References
- 67
- Citations by year
- 2026: 925 · 2025: 1030 · 2024: 865 · 2023: 638 · 2022: 325 · 2021: 48
- FWCI
- 73.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Molecular Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo
- Deakin Research Online (Deakin University) (cc-by)
- Funders
- Fundación Alicia Koplowitz (PI19/00394)
- Wellcome Trust
- National Institute for Health and Care Research
- University College London
- European Commission (CPII19/00009)
- Instituto de Salud Carlos III ((CPII19/00009), PI19/00394)
- European Regional Development Fund (PI19/00394, CPII19/00009)
- European Social Fund (CPII19/00009, PI19/00394)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- age of onset, mental illness, child psychopathology, adolescent mental disorders, neurodevelopmental disorders, anxiety disorders, obsessive-compulsive disorder, eating disorders, substance use disorders, mood disorders, psychosis, bipolar disorder, depression, schizophrenia spectrum disorders, psychosis spectrum disorders, early intervention, mental health promotion, global prevalence estimates
- MeSH terms
- Autism Spectrum Disorder, Alcoholism, Mental Disorders, Cross-Sectional Studies, Humans, Obsessive-Compulsive Disorder, Comorbidity, Prevalence, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.